• A Field Maturing: The 2013 Consumer Genetics Conference

    Sep 30, 2013, 12:00 PM by Michael Croft
    Bio-IT World | The 5th annual Consumer Genetics Conference wrapped up last Friday in Boston, after three days of rich discussion, new ideas and products, and a bit of debate.
    Full story
  • Steve Jobs and Foundation Medicine

    Sep 30, 2013, 09:00 AM by Michael Croft
    Technology Review | With Foundation Medicine's successful IPO, the cancer genetics test that Steve Jobs hoped for will soon be available.
    Full story
  • NIH Announces $25m Grants to Develop Framework for Evaluating Genetic Variants

    Sep 25, 2013, 20:00 PM by Michael Croft
    Bio-IT World | The National Institutes of Health just announced three grants totaling more than $25 million over four years to help three research groups develop authoritative information on the millions of genomic variants relevant to human disease and the hundreds that are expected to be useful for clinical practice.
    Full story
  • PacBio, Roche Sign Deal for Diagnostics

    Sep 25, 2013, 12:00 PM by Michael Croft
    Motley Fool | A Pacific Biosciences-Roche deal announced today has PacBio stock leaping. The deal gives Roche worldwide exclusive rights to in vitro diagnostics products based on PacBio's SMRT technology.
    Full story
  • The Personalized Medicine Business Model

    Sep 25, 2013, 12:00 PM by Michael Croft
    Forbes | Personalized medicine offers tremendous potential for patients, but could impose huge development costs that might never be recovered by the manufacturers.
    Full story
  • Out of Many, One: Genohub’s One-Stop-Shop for NGS Services

    Sep 25, 2013, 06:00 AM by Michael Croft
    By Bio-IT World | The launch of Genohub, a company that helps link genomics researchers with sequencing providers, this past August marks a significant step forward in the Next Generation Sequencing industry.
    Full story
  • Agilent to Divide Into Two Companies

    Sep 24, 2013, 13:00 PM by Michael Croft

    SpectroscopyNOW | Agilent Technologies is preparing to divide in two, with its electronic measurement business forming a separate company.

    Full story
  • RainDance Raises Another $35m

    Sep 24, 2013, 08:00 AM by Michael Croft
    Gigaom | RainDance Technologies has raised $35 million in debt financing from Capital Royalty Partners. The company raised $20 million in April.
    Full story
  • Skipping Exons: New Gene Therapy

    Sep 24, 2013, 08:00 AM by Michael Croft
    New York Times | Sarepta Therapeutics has developed a drug that may be helping muscular dystrophy by skipping exons.
    Full story
  • Oracle Strikes Back at HANA

    Sep 24, 2013, 07:00 AM by Michael Croft
    Computerworld | It's been clear that SAP's HANA was intended to go after Oracle customers, but Oracle is not surrendering.
    Full story
  • Biotech Exec Shoots Two

    Sep 20, 2013, 14:00 PM by Michael Croft
    Xconomy | Hans Petersen, the CEO of a now-defunct San Diego biotech shot and wounded two business associates yesterday.
    Full story
  • Google on Aging

    Sep 20, 2013, 11:00 AM by Michael Croft
    Bio-IT World Roundup | Google announced Calico yesterday, its new venture that is taking on aging. The story predictably solicited comment from around the Web.
    Full story
  • Calling for Action

    Sep 19, 2013, 10:00 AM by Michael Croft
    Opiniomics | Mick Watson knows we need some caution, but he's ready to get moving. On his blog today, he challenged the community to give up the hypothetical examples and start sequencing.
    Full story
  • Life Technologies Names First Group in Centers of Excellence Program

    Sep 19, 2013, 08:00 AM by Michael Croft
    Bio-IT World News Brief | Life Technologies has named its first Next-Generation Sequencing (NGS) Center of Excellence—an initiative to establish a global alliance comprised of leading centers capable of running the most-advanced, NGS-based oncology panels for clinical research.
    Full story
  • NIH Distributes $45 Million for Alzheimer's Research

    Sep 18, 2013, 12:00 PM by Michael Croft
    Bio-IT World News Brief | The National Institutes of Health distributed $45 million in new funding today to support innovative new studies of Alzheimer’s disease.
    Full story
  • Planning for Productivity

    Sep 18, 2013, 08:00 AM by Michael Croft
    Bio-IT World | Productivity doesn’t simply happen, especially in drug discovery. Forecasting and planning drug development can be a painstaking process, but carefully managing resources can lead to progress and savings. At the 11th annual Strategic Resource Management event, speakers from across the drug discovery landscape will share best practices on resource management, decision-making, forecasting, and more.
    Full story
  • FDA Center Chooses New Product Vigilance Software

    Sep 17, 2013, 12:00 PM by Michael Croft
    Bio-IT World News Brief | November Research Group’s PRIMO software platform has been selected as the new product vigilance software solution for the United States Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH).
    Full story
  • DNAnexus Launches NGS Platform-as-a-Service

    Sep 17, 2013, 08:00 AM by Michael Croft
    Bio-IT World News Brief | DNAnexus has launched a specialized platform-as-a-service (PaaS) designed to eliminate the common challenges and costs that enterprises face when building clinically compliant analysis pipelines for next-generation sequencing (NGS) data.  DNAnexus provides a configurable API-based platform that enables clinical testing labs to efficiently move their analysis pipelines into the cloud, using their own algorithms alongside industry-recognized tools and resources to create customized workflows in a secure and compliant environment.
    Full story
  • Grants for Newborn Genomic Sequencing

    Sep 17, 2013, 08:00 AM by Michael Croft
    Healio | Four groups have been awarded $5 million grants under the Genomic Sequencing and Newborn Screening Disorders research program.
    Full story
  • Complete Genomics Names SVP, General Counsel

    Sep 17, 2013, 07:00 AM by Michael Croft
    Bio-IT World News Brief | Complete Genomics has appointed Ethan Knowlden as senior vice president, general counsel, and secretary of the company, now a wholly-owned subsidiary of BGI-Shenzhen.
    Full story